2 unknown, 1 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow NeoVista: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy NeoVista Ophthalmic System - Age Related Macular Degeneration | Phase 1 / Phase 2 | Unknown | NeoVista | 32 | 2008-11-01 | 2011-07-27 |
| A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy NeoVista Ophthalmic System - Wet Age-related Macular Degeneration | Phase 2 | Completed | NeoVista | 20 | 2007-12-01 | 2011-07-27 |
| A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration Epi-Rad90™ Ophthalmic System, ranibizumab - Macular Degeneration | Phase 3 | Unknown | NeoVista | 494 | 2007-04-01 | 2011-07-27 |
Ranibizumab (1)
United States (3) · Israel (2) · United Kingdom (2) · Austria (1) · Germany (1) · Ireland (1) · Peru (1) · Spain (1) · Switzerland (1)
Jeffrey A Nau, MMS (2) · Jeffrey S Heier, MD (1) · Michael Singer, MD (1) · Pravin Dugel, MD (1) · Tim Jackson, MD (1)